Premium
O2‐02‐02: Brain Aβ amyloid measures and MRI are complimentary predictors of progression from MCI to Alzheimer's disease
Author(s) -
Jack Clifford R.,
Wiste Heather J.,
Vemuri Prashanthi,
Weigand Stephen D.,
Senjem Matthew L.,
Knopman David S.,
Bernstein Matt A.,
Gunter Jeffrey L.,
Aisen Paul S.,
Weiner Michael W.,
Petersen Ronald C.,
Jagust William J.,
Shaw Leslie M.,
Trojanowski John Q.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.307
Subject(s) - atrophy , pittsburgh compound b , biomarker , neuroimaging , medicine , amyloid (mycology) , alzheimer's disease neuroimaging initiative , neurodegeneration , magnetic resonance imaging , pathology , hazard ratio , imaging biomarker , dementia , oncology , nuclear medicine , disease , radiology , chemistry , psychiatry , confidence interval , biochemistry